Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation.
Atrial fibrillation
Fibrin clot
Neutrophil-activating peptide 2
Oxidative stress
Journal
Translational stroke research
ISSN: 1868-601X
Titre abrégé: Transl Stroke Res
Pays: United States
ID NLM: 101517297
Informations de publication
Date de publication:
09 Jun 2023
09 Jun 2023
Historique:
received:
06
03
2023
accepted:
30
05
2023
revised:
23
05
2023
medline:
9
6
2023
pubmed:
9
6
2023
entrez:
9
6
2023
Statut:
aheadofprint
Résumé
Neutrophil-activating peptide 2 (NAP-2, CXCL7), a platelet-derived neutrophil chemoattractant, is involved in inflammation. We investigated associations between NAP-2 levels, neutrophil extracellular traps (NETs) formation, and fibrin clot properties in atrial fibrillation (AF). We recruited 237 consecutive patients with AF (mean age, 68 ± 11 years; median CHA
Identifiants
pubmed: 37294500
doi: 10.1007/s12975-023-01165-1
pii: 10.1007/s12975-023-01165-1
pmc: PMC10250863
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Uniwersytet Jagielloński Collegium Medicum
ID : N41/DBS/000906
Informations de copyright
© 2023. The Author(s).
Références
Immunol Rev. 2000 Oct;177:204-16
pubmed: 11138777
Int J Cardiol. 2008 Nov 12;130(2):165-73
pubmed: 18585800
Exp Biol Med (Maywood). 2019 Jan;244(1):22-27
pubmed: 30638058
Thromb Res. 2012 Sep;130(3):e123-8
pubmed: 22503653
Thromb Res. 2015 Aug;136(2):408-14
pubmed: 26048399
Int J Cardiol. 2022 Oct 15;365:1-7
pubmed: 35868355
Pol Arch Intern Med. 2022 Jun 29;132(6):
pubmed: 35488813
Int J Cardiol. 2017 Sep 15;243:244-250
pubmed: 28571619
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2763-8
pubmed: 17901373
Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):249-53
pubmed: 13679651
Europace. 2023 Mar 30;25(3):793-803
pubmed: 36603845
J Autoimmun. 2015 Dec;65:30-7
pubmed: 26283469
Blood. 2016 Aug 11;128(6):753-62
pubmed: 27354721
J Thromb Haemost. 2006 May;4(5):1029-36
pubmed: 16689755
Pol Arch Med Wewn. 2011 Nov;121(11):400-7
pubmed: 22064373
Cardiovasc Res. 2023 Mar 17;119(1):94-111
pubmed: 36662542
JCI Insight. 2021 Sep 22;6(18):
pubmed: 34324440
Front Oncol. 2021 Feb 10;10:599363
pubmed: 33643903
Circulation. 2001 Dec 11;104(24):2886-91
pubmed: 11739301
Transl Stroke Res. 2022 Jun;13(3):364-369
pubmed: 34455571
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):554-569
pubmed: 31914791
J Atr Fibrillation. 2014 Oct 31;7(3):1112
pubmed: 27957114
Blood. 2013 May 30;121(22):4555-66
pubmed: 23550035
Int J Cardiol. 2009 Jul 10;135(3):361-9
pubmed: 18640731
Eur Heart J. 2006 Jan;27(2):136-49
pubmed: 16278230
Front Immunol. 2017 Oct 02;8:1248
pubmed: 29038657
Front Oncol. 2021 Oct 08;11:754221
pubmed: 34692540
Can J Cardiol. 2020 Jan;36(1):119-126
pubmed: 31740169
Stroke. 2018 Nov 21;:STROKEAHA118023712
pubmed: 30580709
Circulation. 1997 Jan 21;95(2):489-96
pubmed: 9008468
Circulation. 2001 Jul 10;104(2):174-80
pubmed: 11447082
Cardiovasc Res. 2019 Jan 1;115(1):31-45
pubmed: 30388199
Redox Biol. 2020 Jan;28:101344
pubmed: 31639650
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Cell Signal. 2019 Feb;54:69-80
pubmed: 30465827
Stroke. 2017 Oct;48(10):2716-2722
pubmed: 28904234
J Am Coll Cardiol. 2006 Oct 17;48(8):1591-9
pubmed: 17045893
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Ann Intensive Care. 2021 Jul 17;11(1):113
pubmed: 34273008
Thromb Res. 2022 May;213:1-7
pubmed: 35276507
Thromb Res. 2011 Dec;128(6):e113-8
pubmed: 21824645
Kardiol Pol. 2023;81(1):14-21
pubmed: 36043418
Thromb Haemost. 2015 Jun;113(6):1224-35
pubmed: 25880990